Companies Nuclera

Making proteins accessible

Spotlight

Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. The eProtein DiscoveryTM platform enables users to go from DNA to protein in less than 48 hours, empowering researchers with easy access to target proteins and accelerating breakthrough improvements in human health

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more

Insights

Read More